A 10-Year-old Girl With Late Acute Lymphoblastic Leukemia Recurrence Diagnosed With COVID-19 and Treated With Remdesivir.
J Pediatr Hematol Oncol
; 44(2): e537-e538, 2022 03 01.
Article
en En
| MEDLINE
| ID: mdl-33885040
ABSTRACT
Patients with hemato-oncologic diseases are particularly vulnerable to severe infections. Adult patients with blood cancers infected with SARS-CoV-2 had poorer treatment outcomes and higher mortality than patients with COVID-19 without burden. However, in pediatric patients with hemato-oncologic diseases the course of COVID-19 is milder than in adults in the same group of patients. In this report, we describe the case of our patient with acute lymphoblastic leukemia infected with SARS-CoV-2 and treated with remdesivir. We also review the existing literature of pediatric patients who have been diagnosed with both hemato-oncologic diseases and COVID-19.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Antivirales
/
Adenosina Monofosfato
/
Alanina
/
Leucemia-Linfoma Linfoblástico de Células Precursoras
/
SARS-CoV-2
/
Tratamiento Farmacológico de COVID-19
/
Recurrencia Local de Neoplasia
Tipo de estudio:
Diagnostic_studies
/
Prognostic_studies
Límite:
Child
/
Female
/
Humans
Idioma:
En
Revista:
J Pediatr Hematol Oncol
Asunto de la revista:
HEMATOLOGIA
/
NEOPLASIAS
/
PEDIATRIA
Año:
2022
Tipo del documento:
Article